USPTO serial 87931502
LECONVIN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 12, 2019
- Examiner
- FLETCHER, TRACY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with LECONVIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Medoncare Pharmaceutical Co., Ltd.
Changsha, Hunan Prov., CN
Other trademarks owned by Medoncare Pharmaceutical Co., Ltd.
Medoncare Pharmaceutical Co., Ltd.
Changsha, Hunan Prov., CN
Other trademarks owned by Medoncare Pharmaceutical Co., Ltd.
Medoncare Pharmaceutical Co., Ltd.
Changsha, Hunan Prov., CN
Other trademarks owned by Medoncare Pharmaceutical Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy T. Wang
TIMOTHY T. WANG Ni, Wang & Massand PLLC8140 WALNUT HILL LANE, SUITE 500DALLAS, TX 75231UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Tonics of medicines, namely, medicinal tea; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, rhinitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Medicinal drinks; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Chemical-pharmaceutical preparations for tumor-suppression and antiviral treatment; Injectable syringes sold filled with vaccines, antivirals and tumor-suppression agents; Troches, namely, tablets for use in tumor-suppression, as antivirals and for the treatment of chronic gastrointestinal disease; Tinctures in the nature of medicinal herb extracts; Tincture of iodine; Tinctures in the nature of antiseptics for use in the treatment of traumatic injuries; Herbs for medicinal purposes; Nutritional supplements; Dietetic foods, namely, dietetic crackers, dietetic sugar for medical use, Dietetic sugar substitutes for medical use; Dietary and nutritional supplements; Dietary food supplements; Dietary supplemental drinks; Dietary supplements; Dietetic beverages adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic foods and beverages adapted for medical use; Nutraceuticals for use as a dietary supplement; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels | SECTION 8 - CANCELLED | Jun 20, 2019 |
| 032 | Beer; Water beverages; Non-alcoholic malt beverages; Non-alcoholic beverages containing fruit juices; Non-alcoholic water-based beverages; Aerated water; Non-alcoholic beverages flavored with tea; Vegetable drink; Preparations for making beverages, namely, fruit drinks; Syrups for beverages; Concentrates and powders used in the preparation of energy drinks and fruit-flavored beverages; Energy drinks; Energy drinks enhanced with vitamins, minerals, nutrients; Isotonic beverages; Isotonic drinks; Isotonic non-alcoholic drinks; Powders used in the preparation of isotonic sports drinks and sports beverages; Protein-enriched sports beverages; Sports drinks; Sports drinks enhanced with vitamins, minerals, nutrients; Sports drinks, namely, energy drinks; Sports drinks, namely, performance drinks; Whey beverages | SECTION 8 - CANCELLED | Jun 20, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Medoncare Pharmaceutical Co., Ltd.
- Other trademarks owned by Medoncare Pharmaceutical Co., Ltd.
- Other trademarks owned by Medoncare Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 032
- Similar marks named LECONVIN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 22, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Nov 12, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 12, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 8, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 7, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 5, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 5, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 17, 2019 | IUAF | USE AMENDMENT FILED | — |
| Sep 17, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 26, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 29, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 29, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 9, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 22, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 21, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 21, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 21, 2018 | ALIE | ASSIGNED TO LIE | — |
| Dec 18, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 17, 2018 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jul 17, 2018 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jul 17, 2018 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jul 13, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 1, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 31, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 25, 2018 | NWAP | NEW APPLICATION ENTERED | — |